After 8 Years of Ozempic, Is Our National Health Any Better?
Ozempic, first approved in 2017, is a blockbuster medication prescribed for everything from diabetes to weight loss to heart disease. Remarkably, one in eight US adults has taken either Ozempic or a similar GLP-1 medicine, such as Wegovy or Zepbound, at some point in their lives. In 2025, the US spent nearly $72 billion on GLP-1s, up 500% from 2018.As a family physician specializing in obesity and diabetes management, I’ve seen how life-changing Ozempic and other GLP-1 medications can be. People...